Precision Virologics Awarded NIH Grant for Gene Therapy Program

Precision Virologics Awarded NIH Grant for Gene Therapy Program

Precision Virologics Awarded NIH Grant for Gene Therapy Program

September 18, 2018

Precision Virologics, Inc. has received an NIH STTR grant entitled, “Novel platform technology for hemophilia gene therapy”. This grant of $215,085 will allow Precision to progress our gene therapy for hemophilia program.